It's not just your weight and your waistline that can improve with allulose intake
Opportunities for Manufacturers in UMIC: How Price Reduction Can Drive Adoption Source: UMIC countries as per World Bank definition In price-sensitive markets, affordability not awareness is the dominant adoption gate for GLP-1 obesity therapies
The problem with a lot of vitamin C formulations Well, definitely not all products that claim to contain vitamin C can do all those things to the same extent
Specifically, loss of function variants identified in Nicastrin (NCSTN), Presenilin Enhancer 2 (PSENEN2), Presenilin 1 (PSEN1), Aph-1A and Aph-1B Gamma-Secretase Subunits (APH1A and APH1B) genes, lead to haplo-insufficiency that ultimately results in defective Notch signaling [46,47,48,49,50]
Trulicity can produce modest weight loss as a secondary effect of its GLP-1 mechanism
Rowlands J, Cruzat V, Carlessi R, Newsholme P